SARS-CoV-2 Is Not Special, but the Pandemic Is: The Ecology, Evolution, Policy, and Future of the Deadliest Pandemic in Living Memory

Abstract

The COVID-19 pandemic is extraordinary, but many ordinary events have contributed to its becoming and persistence. Here, we argue that the emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, which has radically altered day-to-day life for people across the globe, was an inevitability of contemporary human ecology, presaged by spillovers past. We show the ways in which the emergence of this virus reiterates other infectious disease crises, from its origin via habitat encroachment and animal use by humans to its evolution of troublesome features, and we spotlight a long-running crisis of inequitable infectious disease incidence and death. We conclude by describing aspects of SARS-CoV-2 and the COVID-19 pandemic that present opportunities for disease control: spaces for intervention in infection and recovery that reduce transmission and impact. There are no more “before times”; therefore, we encourage embracing a future using old mitigation tactics and government support for ongoing disease control. Expected final online publication date for the Annual Review of Anthropology Volume 51 is October 2022. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.

Mitigating COVID-19 Mortality and Morbidity in China's Aging Population: A Focus on Available Medications and Future Developments

“…The COVID-19 pandemic has initiated numerous debates and stimulated research in aging and related domains, while geriatric adjustments have become more pronounced in a variety of sub-disciplines on the frontline, and later in disciplines covering the sequelae of COVID-19 and Long-COVID [ 13 ]. The “gero-pandemic” has perpetuated investigations of potential targets of both aging and pathological processes, as well as their convergence [ 14 , 15 ].…”

Reversible rearrangement of the cellular cytoskeleton: A key to the broad-spectrum antiviral activity of novel amphiphilic polymers

“…The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the third highly pathogenic zoonotic coronavirus that emerged in the human population in the 21 st century. Although the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) heightened our awareness of the potential biological hazards posed by this viral family, SARS-CoV-2 has had a far more devastating impact on global health, social structures, and economic stability, unparalleled since the Spanish influenza pandemic [ [1] , [2] , [3] ]. As per the data accessible via the World Health Organization (WHO) website, the SARS-CoV-2 pandemic has thus far resulted in over 6.9 million fatalities, notwithstanding the availability of vaccines and targeted therapeutics ( https://covid19.who.int/ , accessed May 18, 2023).…”